Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2002-2010.
Prepublished online as a Blood First Edition Paper on June 7, 2005; DOI 10.1182/blood-2004-04-1622.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-04-1622v1
106/6/2002    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, B. Y
Right arrow Articles by Ochi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, B. Y
Right arrow Articles by Ochi, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 28, 2004
Accepted May 11, 2005

The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells

Bruce Y Ma, Sebastian A Mikolajczak, Ali Danesh, Karoline A Hosiawa, Cheryl M Cameron, Akifumi Takaori-Kondo, Takashi Uchiyama, David J Kelvin, and Atsuo Ochi*

Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
Department of Microbiology and Immunology, University Health Network, Toronto, Ontario, Canada
Department of Microbiology and Immunology, University Health Network, Toronto, Ontario, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Department of Microbiology and Immunology, University Health Network, Toronto, Ontario, Canada; Department of Microbiology and Immunology, The University of Western Ontario, London, Ontario, Canada
The University of Western Ontario, Graduate School of Medicine, Kyoto University, Kyoto, Japan

* Corresponding author; email: aochi{at}uhnresearch.ca.

OX40 and 4-1BB are members of TNF family of costimulatory receptors whose signaling is important for differential immune responses mediated by CD4+ or CD8+ T cells. Although activated T cells may acquire OX40/4-1BB double positive phenotype and signaling from each receptor is expected to influence cell functions, the relevance between OX40 and 4-1BB has never been investigated before. While investigating the expression of OX40 and 4-1BB on activated human T cells we have found that they colocalize. The study of receptor gene-transfected cells showed that both receptor coendocytose and the complex of OX40 and 4-1BB was detectable by specific ligands or Abs. The heterodimer of OX40 and 4-1BB was identified by SDS-PAGE under nonreduced condition and found to associate with TRAF family proteins in a unique manner. Furthermore, the stimulation of OX40/4-1BB rendered cells sensitive to TNF-{alpha} induced apoptosis that accompanied reduced activation of NF-{kappa}B. Finally, the OX40/4-1BB stimulation repressed the mitogen response by activation induced CD25+CD4+ T cells and pre-activated CD8+ T cells. Thus, the OX40/4-1BB heterodimer appears to represent a unique regulatory receptor in activated T cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. W. Wlodarski, Z. Nearman, A. Jankowska, N. Babel, J. Powers, P. Leahy, H.-D. Volk, and J. P. Maciejewski
Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia
J. Leukoc. Biol., March 1, 2008; 83(3): 589 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-W. Lee, Y. Park, A. Song, H. Cheroutre, B. S. Kwon, and M. Croft
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
J. Immunol., October 1, 2006; 177(7): 4464 - 4472.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020